Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan;4(1):63-81.
doi: 10.1177/1756283X10378925.

Treatment of alcoholic liver disease

Affiliations

Treatment of alcoholic liver disease

Thomas H Frazier et al. Therap Adv Gastroenterol. 2011 Jan.

Abstract

Alcoholic liver disease (ALD) remains a major cause of liver-related mortality in the US and worldwide. The correct diagnosis of ALD can usually be made on a clinical basis in conjunction with blood tests, and a liver biopsy is not usually required. Abstinence is the hallmark of therapy for ALD, and nutritional therapy is the first line of therapeutic intervention. The role of steroids in patients with moderate to severe alcoholic hepatitis is gaining increasing acceptance, with the caveat that patients be evaluated for the effectiveness of therapy at 1 week. Pentoxifylline appears to be especially effective in ALD patients with renal dysfunction/hepatorenal syndrome. Biologics such as specific anti-TNFs have been disappointing and should probably not be used outside of the clinical trial setting. Transplantation is effective in patients with end-stage ALD who have stopped drinking (usually for ≥6 months), and both long-term graft and patient survival are excellent.

Keywords: alcoholic liver disease; cytokines; diagnosis; nutrition; steroids; transplantation; treatment.

PubMed Disclaimer

References

    1. Addolorato G., Leggio L., Ferrulli A., Cardone S., Vonghia L., Mirijello A., et al. (2007) Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet 370: 1915–1922 - PubMed
    1. Addolorato G., Russell M., Albano E., Haber P.S., Wands J.R., Leggio L. (2009) Understanding and treating patients with alcoholic cirrhosis: an update. Alcohol Clin Exp Res 33: 1136–1144 - PubMed
    1. Akerman P.A., Cote P.M., Yang S.Q., McClain C., Nelson S., Bagby G., et al. (1993) Long-term ethanol consumption alters the hepatic response to the regenerative effects of tumor necrosis factor-alpha. Hepatology 17: 1066–1073 - PubMed
    1. Akriviadis E., Botla R., Briggs W., Han S., Reynolds T., Shakil O. (2000) Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 119: 1637–1648 - PubMed
    1. Alexander J.F., Lichner M.W., Galambos J.T. (1971) Natural history of alcoholic hepatitis. The long-term prognosis. Am J Gastroenterol 56: 515–525 - PubMed

LinkOut - more resources